OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis and bioactivity evaluation of ferrocene-based hydroxamic acids as selective histone deacetylase 6 inhibitors
Jiangkun Yan, Kairui Yue, Xuejing Fan, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 115004-115004
Closed Access | Times Cited: 16

Showing 16 citing articles:

How does ferrocene correlate with ferroptosis? Multiple approaches to explore ferrocene-appended GPX4 inhibitors as anticancer agents
Wei Li, Jing Yu, Jing Wang, et al.
Chemical Science (2024) Vol. 15, Iss. 27, pp. 10477-10490
Open Access | Times Cited: 11

Synthesis and Bio-evaluation of Aminoferrocene-Based Anticancer Prodrugs as Potent Ferroptosis Inducers
Qianer Zhang, Xuejing Fan, Huimei Qian, et al.
Inorganic Chemistry Frontiers (2025)
Closed Access

Ferrocene Derivatives as Histone Deacetylase Inhibitors: Synthesis and Biological Evaluation
Rostislava Angelova, Georgi Stavrakov
Organics (2025) Vol. 6, Iss. 1, pp. 4-4
Open Access

Remarkable contribution of ferrocene as anticancer agent: An updated review (2020–2024)
Anchal Sharma, Rupali Rana, Nitish Kumar, et al.
Inorganic Chemistry Communications (2025) Vol. 175, pp. 114155-114155
Closed Access

Two cinnamoyl hydroxamates as potential quorum sensing inhibitors against Pseudomonas aeruginosa
Deng Pan, Hua Wu, Junjian Li, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 3

Hydroxamic acid hybrids: Histone deacetylase inhibitors with anticancer therapeutic potency
Yuan Jiang Pan, Haodong Hou, Bo Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115879-115879
Closed Access | Times Cited: 8

Recent developments of hydroxamic acid hybrids as potential anti-breast cancer agents
Xinran Cao, Yufeng Gong
Future Medicinal Chemistry (2024) Vol. 16, Iss. 5, pp. 469-492
Open Access | Times Cited: 2

Ansa–Ferrocene Derivatives as Potential Therapeutics
Marcin Cybulski, Olga Michalak, Włodzimierz Buchowicz, et al.
Molecules (2024) Vol. 29, Iss. 20, pp. 4903-4903
Open Access | Times Cited: 2

Deciphering the Diversified Metabolic Behavior of Hydroxyalkyl Ferrocidiphenols as Anticancer Complexes
Hui Wang, Xuejing Fan, Pei‐Pei Xie, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 2, pp. 1209-1224
Open Access | Times Cited: 6

Design, synthesis, biological evaluation and molecular docking study of novel quinolone derivatives as potent HDAC1 (Histone Deacetylase) inhibitors and anticancer agents
Vahid Eskandarpour, Farzin Hadizadeh, Khalil Abnous, et al.
Journal of Molecular Structure (2024), pp. 141011-141011
Closed Access | Times Cited: 1

Ferrocene modified analogues of imatinib and nilotinib as potent anti-cancer agents
Irena Philipova, Rositsa Mihaylova, Georgi Momekov, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 5, pp. 880-889
Closed Access | Times Cited: 3

Synthesis and Antiproliferative Effect of New Alkyne-Tethered Vindoline Hybrids Containing Pharmacophoric Fragments
Etelka Ferenczi, Péter Keglevich, Bizhar Ahmed Tayeb, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7428-7428
Open Access

Homoleptic Ferrocenyl Stibine and Bismuthine: Synthesis and Characterization
Rocio Rosales, Claudia P. Villamizar C, Rodary Dymarcus, et al.
Russian Journal of Inorganic Chemistry (2023) Vol. 68, Iss. 14, pp. 1963-1971
Closed Access | Times Cited: 1

Page 1

Scroll to top